Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calcium ion binding	DAG1 DGKB CDH23 ADGRV1 NELL2 FAT1 HMCN2 BRAF CRNN VWA2 ALOX15B NPNT HSPG2 FBLN7 PCDHGB2 CAPS PCDHB6 PCDHB3 PCDHAC2 CASR RHOT2 DCHS1 LRP4	2.46e-06	749	203	23	GO:0005509
GeneOntologyMolecularFunction	antigen binding	IGHV3-30-5 IGHV3-38-3 IGHV3-49 IGHV3-38 IGHV3-33 IGHV3-30 EP400 IGHV3-9 IGHV3-30-3 EP300	2.57e-05	190	203	10	GO:0003823
GeneOntologyMolecularFunction	dihydroorotase activity	DHODH CAD	1.03e-04	2	203	2	GO:0004151
GeneOntologyMolecularFunction	type II transforming growth factor beta receptor binding	AMH TGFBR3 CD44	2.13e-04	12	203	3	GO:0005114
GeneOntologyMolecularFunction	alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity	MGAT4B MGAT4A	3.06e-04	3	203	2	GO:0008454
GeneOntologyBiologicalProcess	cell morphogenesis	SPRY3 DACT2 DAG1 CDH23 PLXND1 BRWD3 BAP1 NELL2 FAT1 HMCN2 PTPRD BRAF PTPRS AHR TSC22D4 CDK5R2 CNTN2 SEMA6B HSPG2 FLNB DCDC2 DSCAM APBB1 PCDHAC2 LATS1 CD44 DOCK7 LRP4 RIMS2 EP300	2.93e-06	1194	206	30	GO:0000902
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	CDH23 FAT1 HMCN2 PKD1 CNTN2 DSCAM PCDHGB2 PCDHB6 PCDHB3 PCDHAC2 DCHS1	2.96e-06	187	206	11	GO:0007156
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	IL10 CDH23 FAT1 HMCN2 PTPRD PTPRS PKD1 CNTN2 DSCAM PCDHGB2 PCDHB6 PCDHB3 PCDHAC2 DCHS1	3.41e-06	313	206	14	GO:0098742
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	SPRY3 DAG1 PLXND1 NELL2 HMCN2 PTPRD BRAF PTPRS TSC22D4 CDK5R2 CNTN2 SEMA6B HSPG2 DCDC2 DSCAM APBB1 PCDHAC2 CD44 DOCK7 LRP4 RIMS2 EP300	2.54e-05	819	206	22	GO:0120039
GeneOntologyBiologicalProcess	cell projection morphogenesis	SPRY3 DAG1 PLXND1 NELL2 HMCN2 PTPRD BRAF PTPRS TSC22D4 CDK5R2 CNTN2 SEMA6B HSPG2 DCDC2 DSCAM APBB1 PCDHAC2 CD44 DOCK7 LRP4 RIMS2 EP300	2.89e-05	826	206	22	GO:0048858
GeneOntologyBiologicalProcess	neuron projection development	SPRY3 SNX3 DAG1 CDH23 PLXND1 ADGRV1 NELL2 HMCN2 PTPRD BRAF OTOGL PTPRS TSC22D4 CDK5R2 CNTN2 SEMA6B HSPG2 DCDC2 DSCAM APBB1 PCDHAC2 TRIM32 CSPG4 CD44 DOCK7 LRP4 RIMS2 TNXB EP300	3.28e-05	1285	206	29	GO:0031175
GeneOntologyBiologicalProcess	neuron projection morphogenesis	SPRY3 DAG1 PLXND1 NELL2 HMCN2 PTPRD BRAF PTPRS TSC22D4 CDK5R2 CNTN2 SEMA6B HSPG2 DCDC2 DSCAM APBB1 PCDHAC2 DOCK7 LRP4 RIMS2 EP300	5.66e-05	802	206	21	GO:0048812
GeneOntologyBiologicalProcess	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	IL10 PDCD1 RNF168 RC3H1 IGHV3-30-5 AHR GNL1 IGHV3-38-3 IGHV3-49 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-9 IGHV3-30-3 EP300	6.68e-05	462	206	15	GO:0002460
GeneOntologyBiologicalProcess	immunoglobulin mediated immune response	IL10 RNF168 IGHV3-30-5 IGHV3-38-3 IGHV3-49 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-9 IGHV3-30-3	1.32e-04	235	206	10	GO:0016064
GeneOntologyBiologicalProcess	neuron development	SPRY3 SNX3 DAG1 CDH23 PLXND1 ADGRV1 NELL2 HMCN2 PTPRD BRAF OTOGL PTPRS TSC22D4 CDK5R2 CNTN2 SEMA6B HSPG2 DCDC2 DSCAM HCN1 APBB1 PCDHAC2 TRIM32 CSPG4 CD44 DOCK7 LRP4 RIMS2 TNXB EP300	1.35e-04	1463	206	30	GO:0048666
GeneOntologyBiologicalProcess	morphogenesis of a branching epithelium	IL10 DAG1 PLXND1 PKD1 AHR NPNT CASR CSF1 CD44 DCHS1	1.37e-04	236	206	10	GO:0061138
GeneOntologyBiologicalProcess	gland development	IL10 SP3 DAG1 PLXND1 ONECUT1 BRAF PKD1 AHR ALOX15B CCDC40 CAD MUC19 TGFBR3 LATS1 CSF1 CD44	1.62e-04	558	206	16	GO:0048732
GeneOntologyBiologicalProcess	branching morphogenesis of an epithelial tube	DAG1 PLXND1 PKD1 AHR NPNT CASR CSF1 CD44 DCHS1	1.75e-04	198	206	9	GO:0048754
GeneOntologyBiologicalProcess	B cell mediated immunity	IL10 RNF168 IGHV3-30-5 IGHV3-38-3 IGHV3-49 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-9 IGHV3-30-3	1.79e-04	244	206	10	GO:0019724
GeneOntologyBiologicalProcess	axonogenesis	DAG1 PLXND1 NELL2 HMCN2 BRAF PTPRS CDK5R2 CNTN2 SEMA6B HSPG2 DSCAM APBB1 PCDHAC2 DOCK7 LRP4 EP300	1.90e-04	566	206	16	GO:0007409
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	DAG1 CDH23 PLXND1 NELL2 HMCN2 PTPRD BRAF PTPRS CDK5R2 CNTN2 SEMA6B HSPG2 DCDC2 DSCAM APBB1 PCDHAC2 DOCK7 LRP4 EP300	1.91e-04	748	206	19	GO:0048667
GeneOntologyBiologicalProcess	neuron cellular homeostasis	ATP6V1A ATP6V1B1 BAP1 NELL2 TSC22D4 ATP2B3	1.96e-04	84	206	6	GO:0070050
GeneOntologyBiologicalProcess	disaccharide metabolic process	FBP2 BRAF GAA	2.02e-04	12	206	3	GO:0005984
GeneOntologyBiologicalProcess	axon development	DAG1 PLXND1 NELL2 HMCN2 BRAF PTPRS CDK5R2 CNTN2 SEMA6B HSPG2 DSCAM APBB1 PCDHAC2 TRIM32 DOCK7 LRP4 EP300	2.59e-04	642	206	17	GO:0061564
GeneOntologyBiologicalProcess	presynaptic membrane organization	PTPRD CNTN2 LRP4	2.61e-04	13	206	3	GO:0097090
GeneOntologyBiologicalProcess	morphogenesis of a branching structure	IL10 DAG1 PLXND1 PKD1 AHR NPNT CASR CSF1 CD44 DCHS1	2.81e-04	258	206	10	GO:0001763
GeneOntologyBiologicalProcess	macrophage homeostasis	BAP1 CSF1	2.96e-04	3	206	2	GO:0061519
GeneOntologyBiologicalProcess	'de novo' UMP biosynthetic process	DHODH CAD	2.96e-04	3	206	2	GO:0044205
GeneOntologyCellularComponent	lamellipodium membrane	PLXND1 DOCK8 CSPG4 CD44	5.83e-05	22	206	4	GO:0031258
Domain	Ig-like_fold	FCRL2 PDCD1 MYLK OSCAR DAG1 SIGLEC5 ISLR PLXND1 HMCN2 PTPRD PTPRH PTPRS CAMTA1 CNTN2 HSPG2 FLNB MXRA5 CD300LF DSCAM TRIM3 KIR2DL5A FCRL4 TNXB	1.26e-06	706	194	23	IPR013783
Domain	-	FCRL2 PDCD1 MYLK OSCAR DAG1 SIGLEC5 ISLR PLXND1 PTPRD PTPRS CAMTA1 CNTN2 HSPG2 FLNB MXRA5 CD300LF DSCAM TRIM3 KIR2DL5A FCRL4 TNXB	5.83e-06	663	194	21	2.60.40.10
Domain	IGc2	FCRL2 MYLK SIGLEC5 ISLR HMCN2 PTPRD PTPRS CNTN2 HSPG2 MXRA5 DSCAM FCRL4	6.65e-06	235	194	12	SM00408
Domain	Ig_sub2	FCRL2 MYLK SIGLEC5 ISLR HMCN2 PTPRD PTPRS CNTN2 HSPG2 MXRA5 DSCAM FCRL4	6.65e-06	235	194	12	IPR003598
Domain	DUF3398	DOCK6 DOCK8 DOCK7	2.16e-05	6	194	3	PF11878
Domain	DOCK_C/D_N	DOCK6 DOCK8 DOCK7	2.16e-05	6	194	3	IPR021816
Domain	Cadherin-like	DAG1 CDH23 FAT1 PCDHGB2 PCDHB6 PCDHB3 PCDHAC2 DCHS1	2.86e-05	116	194	8	IPR015919
Domain	Ig_I-set	FCRL2 MYLK ISLR HMCN2 PTPRD PTPRS CNTN2 HSPG2 MXRA5 DSCAM	3.06e-05	190	194	10	IPR013098
Domain	I-set	FCRL2 MYLK ISLR HMCN2 PTPRD PTPRS CNTN2 HSPG2 MXRA5 DSCAM	3.06e-05	190	194	10	PF07679
Domain	IG	FCRL2 PDCD1 MYLK OSCAR SIGLEC5 HMCN2 PTPRD PTPRS CNTN2 HSPG2 MXRA5 CD300LF DSCAM KIR2DL5A FCRL4	3.56e-05	421	194	15	SM00409
Domain	Ig_sub	FCRL2 PDCD1 MYLK OSCAR SIGLEC5 HMCN2 PTPRD PTPRS CNTN2 HSPG2 MXRA5 CD300LF DSCAM KIR2DL5A FCRL4	3.56e-05	421	194	15	IPR003599
Domain	EGF_CA	NELL2 FAT1 HMCN2 VWA2 NPNT HSPG2 FBLN7 LRP4	4.11e-05	122	194	8	SM00179
Domain	EGF-like_Ca-bd_dom	NELL2 FAT1 HMCN2 VWA2 NPNT HSPG2 FBLN7 LRP4	4.62e-05	124	194	8	IPR001881
Domain	IG_LIKE	FCRL2 PDCD1 MYLK OSCAR SIGLEC5 ISLR HMCN2 PTPRD PTPRS CNTN2 HSPG2 MXRA5 CD300LF DSCAM KIR2DL5A FCRL4	5.67e-05	491	194	16	PS50835
Domain	Ig-like_dom	FCRL2 PDCD1 MYLK OSCAR SIGLEC5 ISLR HMCN2 PTPRD PTPRS CNTN2 HSPG2 MXRA5 CD300LF DSCAM KIR2DL5A FCRL4	7.54e-05	503	194	16	IPR007110
Domain	Cadherin_CS	CDH23 FAT1 PCDHGB2 PCDHB6 PCDHB3 PCDHAC2 DCHS1	1.43e-04	109	194	7	IPR020894
Domain	ig	FCRL2 SIGLEC5 PTPRD PTPRS CNTN2 HSPG2 DSCAM KIR2DL5A FCRL4	1.71e-04	190	194	9	PF00047
Domain	Immunoglobulin	FCRL2 SIGLEC5 PTPRD PTPRS CNTN2 HSPG2 DSCAM KIR2DL5A FCRL4	1.71e-04	190	194	9	IPR013151
Domain	DHR-1_domain	DOCK6 DOCK8 DOCK7	1.71e-04	11	194	3	IPR027007
Domain	DHR_2	DOCK6 DOCK8 DOCK7	1.71e-04	11	194	3	PS51651
Domain	DHR_1	DOCK6 DOCK8 DOCK7	1.71e-04	11	194	3	PS51650
Domain	DHR-2	DOCK6 DOCK8 DOCK7	1.71e-04	11	194	3	PF06920
Domain	DOCK	DOCK6 DOCK8 DOCK7	1.71e-04	11	194	3	IPR026791
Domain	DOCK_C	DOCK6 DOCK8 DOCK7	1.71e-04	11	194	3	IPR010703
Domain	DOCK-C2	DOCK6 DOCK8 DOCK7	1.71e-04	11	194	3	PF14429
Domain	DHR-2	DOCK6 DOCK8 DOCK7	1.71e-04	11	194	3	IPR027357
Domain	CADHERIN_1	CDH23 FAT1 PCDHGB2 PCDHB6 PCDHB3 PCDHAC2 DCHS1	1.79e-04	113	194	7	PS00232
Domain	Cadherin	CDH23 FAT1 PCDHGB2 PCDHB6 PCDHB3 PCDHAC2 DCHS1	1.79e-04	113	194	7	PF00028
Domain	EGF_3	NELL2 FAT1 HMCN2 VWA2 NPNT HSPG2 FBLN7 ADAM12 LRP4 TNXB	1.80e-04	235	194	10	PS50026
Domain	CADHERIN_2	CDH23 FAT1 PCDHGB2 PCDHB6 PCDHB3 PCDHAC2 DCHS1	1.89e-04	114	194	7	PS50268
Domain	-	CDH23 FAT1 PCDHGB2 PCDHB6 PCDHB3 PCDHAC2 DCHS1	1.89e-04	114	194	7	2.60.40.60
Domain	CA	CDH23 FAT1 PCDHGB2 PCDHB6 PCDHB3 PCDHAC2 DCHS1	1.99e-04	115	194	7	SM00112
Domain	Cadherin	CDH23 FAT1 PCDHGB2 PCDHB6 PCDHB3 PCDHAC2 DCHS1	2.34e-04	118	194	7	IPR002126
Domain	EGF_CA	NELL2 FAT1 HMCN2 NPNT FBLN7 LRP4	2.74e-04	86	194	6	PF07645
Domain	EGF-like_dom	NELL2 FAT1 HMCN2 VWA2 NPNT HSPG2 FBLN7 ADAM12 LRP4 TNXB	2.86e-04	249	194	10	IPR000742
Domain	HIF_alpha_subunit	HIF3A EPAS1	3.20e-04	3	194	2	IPR021537
Domain	HIF-1	HIF3A EPAS1	3.20e-04	3	194	2	PF11413
Domain	EGF_1	NELL2 FAT1 HMCN2 VWA2 NPNT HSPG2 FBLN7 ADAM12 LRP4 TNXB	3.45e-04	255	194	10	PS00022
Domain	EGF-like_CS	NELL2 FAT1 HMCN2 VWA2 NPNT HSPG2 FBLN7 ADAM12 LRP4 TNXB	4.15e-04	261	194	10	IPR013032
Domain	EGF_2	NELL2 FAT1 HMCN2 VWA2 NPNT HSPG2 FBLN7 ADAM12 LRP4 TNXB	4.67e-04	265	194	10	PS01186
Domain	EGF_Ca-bd_CS	NELL2 FAT1 HMCN2 NPNT FBLN7 LRP4	5.25e-04	97	194	6	IPR018097
Domain	EGF_CA	NELL2 FAT1 HMCN2 NPNT FBLN7 LRP4	5.85e-04	99	194	6	PS01187
Domain	ASX_HYDROXYL	NELL2 FAT1 HMCN2 NPNT FBLN7 LRP4	6.17e-04	100	194	6	PS00010
Domain	TSC-22_Dip_Bun	TSC22D1 TSC22D4	6.35e-04	4	194	2	IPR000580
Domain	TSC-22_Dip_Bun	TSC22D1 TSC22D4	6.35e-04	4	194	2	PD007152
Domain	Glyco_transf_54	MGAT4B MGAT4A	6.35e-04	4	194	2	IPR006759
Domain	TSC22	TSC22D1 TSC22D4	6.35e-04	4	194	2	PF01166
Domain	Glyco_transf_54	MGAT4B MGAT4A	6.35e-04	4	194	2	PF04666
Domain	TSC22	TSC22D1 TSC22D4	6.35e-04	4	194	2	PS01289
Domain	Laminin_G_2	NELL2 FAT1 HSPG2 CSPG4	7.70e-04	40	194	4	PF02210
Domain	EGF-type_Asp/Asn_hydroxyl_site	NELL2 FAT1 HMCN2 NPNT FBLN7 LRP4	8.39e-04	106	194	6	IPR000152
Domain	Cadherin_C	PCDHGB2 PCDHB6 PCDHB3 PCDHAC2	9.28e-04	42	194	4	IPR032455
Domain	Cadherin_C_2	PCDHGB2 PCDHB6 PCDHB3 PCDHAC2	9.28e-04	42	194	4	PF16492
Domain	NUT	NUTM2G NUTM2F	1.05e-03	5	194	2	IPR024310
Domain	NUT_N	NUTM2G NUTM2F	1.05e-03	5	194	2	IPR024309
Domain	ATP_synth_asu_C	ATP6V1A ATP6V1B1	1.05e-03	5	194	2	IPR000793
Domain	ATP-synt_ab_N	ATP6V1A ATP6V1B1	1.05e-03	5	194	2	PF02874
Domain	NUT	NUTM2G NUTM2F	1.05e-03	5	194	2	PF12881
Domain	ATPase_F1/V1/A1_a/bsu_N	ATP6V1A ATP6V1B1	1.05e-03	5	194	2	IPR004100
Domain	ATPase_a/bsu_AS	ATP6V1A ATP6V1B1	1.05e-03	5	194	2	IPR020003
Domain	ATP-synt_ab_C	ATP6V1A ATP6V1B1	1.05e-03	5	194	2	PF00306
Domain	ATP-synt_ab	ATP6V1A ATP6V1B1	1.05e-03	5	194	2	PF00006
Domain	ATPASE_ALPHA_BETA	ATP6V1A ATP6V1B1	1.05e-03	5	194	2	PS00152
Domain	LamG	NELL2 FAT1 HSPG2 CSPG4	1.11e-03	44	194	4	SM00282
Domain	Growth_fac_rcpt_	NELL2 FAT1 HMCN2 NPNT HSPG2 LRP4 TNXB	1.24e-03	156	194	7	IPR009030
Domain	6-blade_b-propeller_TolB-like	TECPR2 TRIM3 TRIM32 LRP4	1.31e-03	46	194	4	IPR011042
Domain	Quino_amine_DH_bsu	BRWD3 TEP1 TRIM3	1.47e-03	22	194	3	IPR011044
Domain	fn3	MYLK PTPRD PTPRH PTPRS CNTN2 DSCAM TNXB	1.54e-03	162	194	7	PF00041
Domain	Sec23/24_helical_dom	SEC23B SEC24C	1.57e-03	6	194	2	IPR006900
Domain	Sec23_24_beta_S	SEC23B SEC24C	1.57e-03	6	194	2	IPR012990
Domain	zf-Sec23_Sec24	SEC23B SEC24C	1.57e-03	6	194	2	PF04810
Domain	Sec23_trunk	SEC23B SEC24C	1.57e-03	6	194	2	PF04811
Domain	Sec23_helical	SEC23B SEC24C	1.57e-03	6	194	2	PF04815
Domain	ATPase_F1/V1/A1_a/bsu_nucl-bd	ATP6V1A ATP6V1B1	1.57e-03	6	194	2	IPR000194
Domain	Sec23_BS	SEC23B SEC24C	1.57e-03	6	194	2	PF08033
Domain	Sec23/24_trunk_dom	SEC23B SEC24C	1.57e-03	6	194	2	IPR006896
Domain	Znf_Sec23_Sec24	SEC23B SEC24C	1.57e-03	6	194	2	IPR006895
Domain	PAS_fold_3	AHR HIF3A EPAS1	1.68e-03	23	194	3	IPR013655
Domain	PAS_3	AHR HIF3A EPAS1	1.68e-03	23	194	3	PF08447
Domain	EGF	FAT1 VWA2 HSPG2 FBLN7 LRP4 TNXB	2.04e-03	126	194	6	PF00008
Domain	PAS	AHR HIF3A EPAS1	2.14e-03	25	194	3	PF00989
Domain	PAS_fold	AHR HIF3A EPAS1	2.14e-03	25	194	3	IPR013767
Domain	PKD	PKD1 PMEL	2.18e-03	7	194	2	PF00801
Domain	G_CP_dom	GNL1 GNL3L	2.18e-03	7	194	2	IPR030378
Domain	G_CP	GNL1 GNL3L	2.18e-03	7	194	2	PS51721
Domain	PAC	AHR HIF3A EPAS1	2.41e-03	26	194	3	IPR001610
Domain	PAC	AHR HIF3A EPAS1	2.41e-03	26	194	3	SM00086
Domain	SGNH_hydro	PLB1 SIAE	2.88e-03	8	194	2	IPR013830
Domain	Laminin_G	NELL2 FAT1 HSPG2 CSPG4	3.09e-03	58	194	4	IPR001791
Domain	-	ADGRV1 NELL2 FAT1 HSPG2 CSPG4	3.13e-03	95	194	5	2.60.120.200
Domain	EGF	NELL2 FAT1 VWA2 NPNT HSPG2 FBLN7 LRP4 TNXB	3.24e-03	235	194	8	SM00181
Domain	FN3	MYLK PTPRD PTPRH PTPRS CNTN2 DSCAM TNXB	3.25e-03	185	194	7	SM00060
Domain	NHL_repeat_subgr	TRIM3 TRIM32	3.68e-03	9	194	2	IPR013017
Domain	PKD/Chitinase_dom	PKD1 PMEL	3.68e-03	9	194	2	IPR022409
Domain	PKD	PKD1 PMEL	3.68e-03	9	194	2	SM00089
Domain	VWF_A	HMCN2 VWA2 SEC23B ITIH5 SEC24C	3.73e-03	99	194	5	IPR002035
Domain	PAS	AHR HIF3A EPAS1	4.38e-03	32	194	3	SM00091
Domain	IG_FLMN	FLNB TRIM3	4.57e-03	10	194	2	SM00557
Domain	Sp1_fam	SP3 SP4	4.57e-03	10	194	2	IPR030450
Domain	NHL_repeat	TRIM3 TRIM32	4.57e-03	10	194	2	IPR001258
Pathway	REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR	HIF3A EP300 EPAS1	2.17e-05	6	147	3	MM14521
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MGAT4B INTS1 PLXND1 BAP1 FAT1 ZNF276 PTPRS SGSM2 PKD1 DOCK6 MVB12B SEMA6B HSPG2 EP400 NRF1 NICN1 RHOT2 TEP1 ARSG SIL1 NAPRT CSPG4 HPS6 LRP4 EP300	1.67e-08	1105	210	25	35748872
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ATP6V1A ZNF444 ATXN7L1 ATG13 VPS13C PSMD1 ADGRV1 NEDD1 BRWD3 TSC22D1 TECPR2 PTPRS SGSM2 TSC22D4 CAMTA1 DOCK6 UBR2 FLNB GNL3L FYTTD1 NRF1 RALGAPB TEP1 SIL1 YEATS2 ZFP64 PLEKHA2 CFAP69 EP300	2.94e-08	1489	210	29	28611215
Pubmed	Functional proteomics mapping of a human signaling pathway.	RNF168 PSMD1 PKD1 MGA HSPG2 FLNB KRT7 MRI1 DOCK8 RHOT2 PRDM4 SIL1 RNF123 CSPG4 SPRTN EPAS1	7.24e-07	591	210	16	15231748
Pubmed	A census of human transcription factors: function, expression and evolution.	TRERF1 SP3 SP4 ZNF444 ONECUT1 TSC22D1 NR1I2 NFYA TSC22D4 CAMTA1 MGA ADNP2 HIF3A ZNF524 PRDM4 RFX5 YEATS2 ZSCAN20 ZHX1 EPAS1	7.48e-07	908	210	20	19274049
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	ATP6V1A ATP6V1B1 SNX3 VPS13C FBP2 ALDH1L1 ADGRV1 SIAE FAT1 PKD1 CRNN MVB12B HSPG2 FLNB MXRA5 NRF1 RBL2 TGFBR3 NAPRT DCXR GAA	1.08e-06	1016	210	21	19056867
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	ATP6V1A SNX3 VPS13C PLXND1 MCM10 ARFIP1 FAT1 MGA SEC23B KRT5 EP400 DSCAM SYNM APBB1 SEC24C CD44 DOCK7 HSD17B10	1.35e-06	777	210	18	35844135
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	AVL9 ATG13 DGKB ARHGEF17 SGSM2 CAMTA1 UBR2 FKBP15 EP400 RALGAPB YEATS2 SEC24C DOCK7	1.36e-06	407	210	13	12693553
Pubmed	A human MAP kinase interactome.	TPR PSMD1 TSC22D1 BRAF NFYA AGFG1 COG5 MGA KRT5 ADNP2 LATS1 ZHX1 EP300 EPAS1	1.78e-06	486	210	14	20936779
Pubmed	In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.	ATP6V1A ATP6V1B1 OSCAR DAG1 ISLR ALDH1L1 SIAE PTPRD PTPRS GNS ALOX15B HSPG2 FLNB KRT7 IGHV3-9 NAPRT CSPG4 CD44 TNXB DCXR GAA	2.43e-06	1070	210	21	23533145
Pubmed	Degradation, Promoter Recruitment and Transactivation Mediated by the Extreme N-Terminus of MHC Class II Transactivator CIITA Isoform III.	EP400 RFX5 EP300	4.28e-06	6	210	3	26871568
Pubmed	Receptor protein tyrosine phosphatases are novel components of a polycystin complex.	PTPRD PTPRS PKD1	4.28e-06	6	210	3	21126580
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	SPAM1 ATXN7L1 KDM5C EMILIN3 BRWD3 NELL2 ZNF469 FAT1 HMCN2 CRNN AHR MGA GNL3L EP400 ADNP2 RHOT2 TEP1 YEATS2 METTL13 LRP4 EP300	4.66e-06	1116	210	21	31753913
Pubmed	Global proteomics of Ubqln2-based murine models of ALS.	SNX3 ARFIP1 AGFG1 SEC23B FLNB FCHO2 RNF123 LATS1 SEC24C TRIM32	4.74e-06	261	210	10	33277362
Pubmed	Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT).	ATP6V1A ATP6V1B1 MGAT4A DAG1 CRNN VWA2 HSPA6 NPNT HSPG2 KRT5 TGFBR3 CD44	9.98e-06	417	210	12	19199708
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	PSMD1 ARMCX4 BRWD3 NELL2 PTPRD SGSM2 PKD1 FLNB DSCAM SYNM RBL2 HCN1 ADNP2 APBB1 RIPK4 PRDM4 RFX5 RNF123 TRIM32 LRP4 USPL1 EP300	1.21e-05	1285	210	22	35914814
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	TRERF1 SP3 SP4 ZNF469 AGFG1 CAMTA1 MGA EP400 PRDM4 LATS1 SPRTN ZHX1	1.35e-05	430	210	12	35044719
Pubmed	Inflammation-dependent overexpression of c-Myc enhances CRL4DCAF4 E3 ligase activity and promotes ubiquitination of ST7 in colitis-associated cancer.	CDH23 PSMD1 BAP1 HSPG2 KRT7 ZFP64 DOCK7 HSD17B10 EP300	2.89e-05	257	210	9	30945288
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	TPR FKBP15 KRT5 CAD DSCAM DOCK7 EIF5B ATP2B3	3.40e-05	202	210	8	24639526
Pubmed	Transforming growth factor-beta-stimulated clone-22 is a member of a family of leucine zipper proteins that can homo- and heterodimerize and has transcriptional repressor activity.	TSC22D1 TSC22D4	3.63e-05	2	210	2	10488076
Pubmed	Cross-talk between EPAS-1/HIF-2α and PXR signaling pathway regulates multi-drug resistance of stomach cancer cell.	NR1I2 EPAS1	3.63e-05	2	210	2	26783937
Pubmed	Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B.	KIR2DL5B KIR2DL5A	3.63e-05	2	210	2	12185535
Pubmed	Kinetic properties and substrate specificities of two recombinant human N-acetylglucosaminyltransferase-IV isozymes.	MGAT4B MGAT4A	3.63e-05	2	210	2	17006639
Pubmed	EP300 promotes renal tubular epithelial cell fibrosis by increasing HIF2α expression in diabetic nephropathy.	EP300 EPAS1	3.63e-05	2	210	2	35839978
Pubmed	Cell surface chondroitin sulphate proteoglycan 4 (CSPG4) binds to the basement membrane heparan sulphate proteoglycan, perlecan, and is involved in cell adhesion.	HSPG2 CSPG4	3.63e-05	2	210	2	29462330
Pubmed	A combination of p300 and Braf expression in the diagnosis and prognosis of melanoma.	BRAF EP300	3.63e-05	2	210	2	24893747
Pubmed	Acute exercise impacts AhR and PD-1 levels of CD8+ T-cells-Exploratory results from a randomized cross-over trial comparing endurance versus resistance exercise.	PDCD1 AHR	3.63e-05	2	210	2	33211154
Pubmed	Expression of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma cells is downregulated upon inhibition of BRAF.	BRAF CSPG4	3.63e-05	2	210	2	33649790
Pubmed	Physiological and glycomic characterization of N-acetylglucosaminyltransferase-IVa and -IVb double deficient mice.	MGAT4B MGAT4A	3.63e-05	2	210	2	20015870
Pubmed	Evaluation of PD-1 and interleukin-10-receptor expression by T lymphocytes in malignant and benign pleural effusions.	IL10 PDCD1	3.63e-05	2	210	2	39325190
Pubmed	Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis.	IL10 CSF1	3.63e-05	2	210	2	16859503
Pubmed	An Immunosuppressive Effect of Melanoma-derived Exosomes on NY-ESO-1 Antigen-specific Human CD8+ T Cells is Dependent on IL-10 and Independent of BRAFV600E Mutation in Melanoma Cell Lines.	IL10 BRAF	3.63e-05	2	210	2	32799717
Pubmed	Impaired activation of lesional CD8+ T-cells is associated with enhanced expression of Programmed Death-1 in Indian Post Kala-azar Dermal Leishmaniasis.	IL10 PDCD1	3.63e-05	2	210	2	30679687
Pubmed	PD-1 modulates steady-state and infection-induced IL-10 production in vivo.	IL10 PDCD1	3.63e-05	2	210	2	24165808
Pubmed	Imbalance of circulating monocyte subsets and PD-1 dysregulation in Q fever endocarditis: the role of IL-10 in PD-1 modulation.	IL10 PDCD1	3.63e-05	2	210	2	25211350
Pubmed	Nanovesicles From Lactobacillus johnsonii N6.2 Reduce Apoptosis in Human Beta Cells by Promoting AHR Translocation and IL10 Secretion.	IL10 AHR	3.63e-05	2	210	2	35757772
Pubmed	IL10 and PD-1 Cooperate to Limit the Activity of Tumor-Specific CD8+ T Cells.	IL10 PDCD1	3.63e-05	2	210	2	25720800
Pubmed	Aberrant expression of N-acetylglucosaminyltransferase-IVa and IVb (GnT-IVa and b) in pancreatic cancer.	MGAT4B MGAT4A	3.63e-05	2	210	2	16434023
Pubmed	BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations.	BAP1 BRAF	3.63e-05	2	210	2	25479927
Pubmed	The second catalytic domain of protein tyrosine phosphatase delta (PTP delta) binds to and inhibits the first catalytic domain of PTP sigma.	PTPRD PTPRS	3.63e-05	2	210	2	9566880
Pubmed	The Mass1frings mutation underlies early onset hearing impairment in BUB/BnJ mice, a model for the auditory pathology of Usher syndrome IIC.	CDH23 ADGRV1	3.63e-05	2	210	2	15820310
Pubmed	The tumor suppressor BAP1 cooperates with BRAFV600E to promote tumor formation in cutaneous melanoma.	BAP1 BRAF	3.63e-05	2	210	2	30156010
Pubmed	The aryl hydrocarbon receptor promotes IL-10 production by NK cells.	IL10 AHR	3.63e-05	2	210	2	24403534
Pubmed	Aryl hydrocarbon receptor activity downstream of IL-10 signaling is required to promote regulatory functions in human dendritic cells.	IL10 AHR	3.63e-05	2	210	2	36870061
Pubmed	Evidence for the involvement of xenobiotic-responsive nuclear receptors in transcriptional effects upon perfluoroalkyl acid exposure in diverse species.	NR1I2 CASR	3.63e-05	2	210	2	19162173
Pubmed	Programmed death-1 receptor and interleukin-10 in liver transplant recipients at high risk for late cytomegalovirus disease.	IL10 PDCD1	3.63e-05	2	210	2	20070620
Pubmed	Nested and microcystic variants of urothelial carcinoma displaying immunohistochemical features of basal-like urothelial cells: an immunohistochemical and histopathogenetic study.	KRT5 CD44	3.63e-05	2	210	2	25143125
Pubmed	CD44 Interacts with HIF-2α to Modulate the Hypoxic Phenotype of Perinecrotic and Perivascular Glioma Cells.	CD44 EPAS1	3.63e-05	2	210	2	28813675
Pubmed	Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene.	KIR2DL5B KIR2DL5A	3.63e-05	2	210	2	11086080
Pubmed	Human ZHX1: cloning, chromosomal location, and interaction with transcription factor NF-Y.	NFYA ZHX1	3.63e-05	2	210	2	10441475
Pubmed	Flat Intraurothelial Neoplasia Exhibiting Diffuse Immunoreactivity for CD44 and Cytokeratin 5 (Urothelial Stem Cell/Basal Cell Markers): A Variant of Intraurothelial Neoplasia Commonly Associated With Muscle-invasive Urothelial Carcinoma.	KRT5 CD44	3.63e-05	2	210	2	26990746
Pubmed	Dominant-negative HIF-3 alpha 4 suppresses VHL-null renal cell carcinoma progression.	HIF3A EPAS1	3.63e-05	2	210	2	17998805
Pubmed	Abrogation of experimental colitis correlates with increased apoptosis in mice deficient for CD44 variant exon 7 (CD44v7).	IL10 CD44	3.63e-05	2	210	2	10859330
Pubmed	Eurotium cristatum Fermented Loose Dark Tea Ameliorates Cigarette Smoke-Induced Lung Injury by MAPK Pathway and Enhances Hepatic Metabolic Detoxification by PXR/AhR Pathway in Mice.	NR1I2 AHR	3.63e-05	2	210	2	33777316
Pubmed	Association of KIR2DL5B gene with celiac disease supports the susceptibility locus on 19q13.4.	KIR2DL5B KIR2DL5A	3.63e-05	2	210	2	17215859
Pubmed	Posttranslational regulation of NF-YA modulates NF-Y transcriptional activity.	NFYA EP300	3.63e-05	2	210	2	18815279
Pubmed	Identification of IL-10-secreting CD8+CD28-PD-1+ regulatory T cells associated with chronic hepatitis C virus infection.	IL10 PDCD1	3.63e-05	2	210	2	30055200
Pubmed	Afatinib Exerts Immunomodulatory Effects by Targeting the Pyrimidine Biosynthesis Enzyme CAD.	DHODH CAD	3.63e-05	2	210	2	33771897
Pubmed	A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression.	BAP1 BRAF	3.63e-05	2	210	2	22367297
Pubmed	Deterioration of alveolar development in mice with both HIF-3α knockout and HIF-2α knockdown.	HIF3A EPAS1	3.63e-05	2	210	2	29986746
Pubmed	TRIM32 promotes oral squamous cell carcinoma progression by enhancing FBP2 ubiquitination and degradation.	FBP2 TRIM32	3.63e-05	2	210	2	37640002
Pubmed	Cloning by recognition site screening of two novel GT box binding proteins: a family of Sp1 related genes.	SP3 SP4	3.63e-05	2	210	2	1454515
Pubmed	Defective Antigen Presentation Leads to Upregulation of PD1 and IL-10 in HIV-TB Co-Infection.	IL10 PDCD1	3.63e-05	2	210	2	32456524
Pubmed	Investigation of the human FCRL1, 2, and 4 gene expressions in patients with rheumatoid arthritis.	FCRL2 FCRL4	3.63e-05	2	210	2	27193470
Pubmed	Antagonistic TSC22D1 variants control BRAF(E600)-induced senescence.	TSC22D1 TSC22D4	3.63e-05	2	210	2	21448135
Pubmed	Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing.	SP4 DAO ALDH1L1 SURF1 AGFG1 COG5 GNS NRF1 DOCK8 SIL1 ZSCAN20 TRIM32 ZFP64 HSD17B10 NUTM2F	5.06e-05	742	210	15	26871637
Pubmed	The spatiotemporal expression pattern of Syndecans in murine embryonic teeth.	HSPG2 TGFBR3 CSPG4 CD44	5.20e-05	34	210	4	32220631
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	TPR KDM5C BAP1 NFYA COG5 MGA UBR2 EP400 NRF1 RBL2 TRIM3 METTL13 EIF5B ATP2B3 EP300 GAA	7.24e-05	857	210	16	25609649
Pubmed	Identification of an evolutionarily conserved superfamily of DOCK180-related proteins with guanine nucleotide exchange activity.	DOCK6 DOCK8 DOCK7	7.52e-05	14	210	3	12432077
Pubmed	Hypoxia-inducible factor (HIF)-3alpha is subject to extensive alternative splicing in human tissues and cancer cells and is regulated by HIF-1 but not HIF-2.	HIF3A EPAS1	1.08e-04	3	210	2	20416395
Pubmed	Effect of oxygen on the expression of hypoxia-inducible factors in human fetal lung explants.	HIF3A EPAS1	1.08e-04	3	210	2	20551700
Pubmed	Transcriptional regulation of the mouse gene encoding the alpha-4 subunit of the GABAA receptor.	SP3 SP4	1.08e-04	3	210	2	15265862
Pubmed	Trans-synaptic adhesions between netrin-G ligand-3 (NGL-3) and receptor tyrosine phosphatases LAR, protein-tyrosine phosphatase delta (PTPdelta), and PTPsigma via specific domains regulate excitatory synapse formation.	PTPRD PTPRS	1.08e-04	3	210	2	20139422
Pubmed	Defining GM-CSF- and macrophage-CSF-dependent macrophage responses by in vitro models.	IL10 CSF1	1.08e-04	3	210	2	22547697
Pubmed	Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR.	PTPRD PTPRS	1.08e-04	3	210	2	33656439
Pubmed	Genetic dissection of susceptibility to audiogenic seizures in inbred mice.	AHR DOCK7	1.08e-04	3	210	2	2052619
Pubmed	Endothelial cells augment the suppressive function of CD4+ CD25+ Foxp3+ regulatory T cells: involvement of programmed death-1 and IL-10.	IL10 PDCD1	1.08e-04	3	210	2	20382886
Pubmed	Altered DNA binding specificity of Arnt by selection of partner bHLH-PAS proteins.	AHR EPAS1	1.08e-04	3	210	2	15190133
Pubmed	Miller (Genee-Wiedemann) syndrome represents a clinically and biochemically distinct subgroup of postaxial acrofacial dysostosis associated with partial deficiency of DHODH.	DHODH CAD	1.08e-04	3	210	2	22692683
Pubmed	Expression Profile of Human Fc Receptor-Like 1, 2, and 4 Molecules in Peripheral Blood Mononuclear Cells of Patients with Hashimoto's Thyroiditis and Graves' Disease.	FCRL2 FCRL4	1.08e-04	3	210	2	25738996
Pubmed	The acetate/ACSS2 switch regulates HIF-2 stress signaling in the tumor cell microenvironment.	EP300 EPAS1	1.08e-04	3	210	2	25689462
Pubmed	Zinc-fingers and homeoboxes (ZHX) 2, a novel member of the ZHX family, functions as a transcriptional repressor.	NFYA ZHX1	1.08e-04	3	210	2	12741956
Pubmed	Interleukin-10 counteracts T-helper type 1 responses in B-cell lymphoma and is a target for tumor immunotherapy.	IL10 PDCD1	1.08e-04	3	210	2	33524501
Pubmed	Disruption of perlecan binding and matrix assembly by post-translational or genetic disruption of dystroglycan function.	DAG1 HSPG2	1.08e-04	3	210	2	16098969
Pubmed	Genome-wide identification of hypoxia-inducible factor-1 and -2 binding sites in hypoxic human macrophages alternatively activated by IL-10.	IL10 EPAS1	1.08e-04	3	210	2	25450522
Pubmed	Role of Programmed Cell Death Protein-1 and Lymphocyte Specific Protein Tyrosine Kinase in the Aryl Hydrocarbon Receptor- Mediated Impairment of the IgM Response in Human CD5+ Innate-Like B Cells.	PDCD1 AHR	1.08e-04	3	210	2	35558082
Pubmed	Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells.	CD44 EP300	1.08e-04	3	210	2	19047049
Pubmed	CD44 costimulation promotes FoxP3+ regulatory T cell persistence and function via production of IL-2, IL-10, and TGF-beta.	IL10 CD44	1.08e-04	3	210	2	19635906
Pubmed	Outcomes after progression of disease with anti-PD-1/PD-L1 therapy for patients with advanced melanoma.	PDCD1 BRAF	1.08e-04	3	210	2	32463489
Pubmed	Reciprocal expressions between α-dystroglycan and integrin β1, perlecan receptors, in the murine enamel organ development.	DAG1 HSPG2	1.08e-04	3	210	2	23722005
Pubmed	Association of xenobiotic receptor polymorphisms with carbamazepine response in epilepsy patients.	NR1I2 AHR	1.08e-04	3	210	2	33333223
Pubmed	Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomy.	KDM5C BAP1	1.08e-04	3	210	2	28408295
Pubmed	Feedback inhibition of osteoclastogenesis during inflammation by IL-10, M-CSF receptor shedding, and induction of IRF8.	IL10 CSF1	1.08e-04	3	210	2	22082370
Pubmed	Mullerian Inhibiting Substance inhibits cervical cancer cell growth via a pathway involving p130 and p107.	AMH RBL2	1.08e-04	3	210	2	14671316
Pubmed	Curcumin decreases specificity protein expression in bladder cancer cells.	SP3 SP4	1.08e-04	3	210	2	18593936
Pubmed	Regulation of transcription of the Dnmt1 gene by Sp1 and Sp3 zinc finger proteins.	SP3 EP300	1.08e-04	3	210	2	12071960
Pubmed	Developmental expression of the cell adhesion molecule-like protein tyrosine phosphatases LAR, RPTPdelta and RPTPsigma in the mouse.	PTPRD PTPRS	1.08e-04	3	210	2	9784606
Pubmed	Bioactive terpenoids and flavonoids from Ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through pregnane X receptor, constitutive androstane receptor, and aryl hydrocarbon receptor-mediated pathways.	NR1I2 AHR	1.08e-04	3	210	2	19034627
Pubmed	Structural basis for LAR-RPTP/Slitrk complex-mediated synaptic adhesion.	PTPRD PTPRS	1.08e-04	3	210	2	25394468
Pubmed	Madm (Mlf1 adapter molecule) cooperates with Bunched A to promote growth in Drosophila.	TSC22D1 TSC22D4	1.08e-04	3	210	2	20149264
Pubmed	ZFP64 transcriptionally activates PD-1 and CTLA-4 and plays an oncogenic role in esophageal cancer.	PDCD1 ZFP64	1.08e-04	3	210	2	35843097
Interaction	ZNF469 interactions	BRWD3 ZNF469 RIPK4 EP300	6.65e-07	8	202	4	int:ZNF469
Cytoband	14q32.33	IGHV3-30-5 IGHV3-38-3 IGHV3-49 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-9 IGHV3-30-3	1.14e-05	228	210	8	14q32.33
Cytoband	5q31	PCDHGB2 PCDHB6 PCDHB3 PCDHAC2 SIL1	1.95e-04	115	210	5	5q31
GeneFamily	Blood group antigens\|CD molecules\|Proteoglycans	HSPG2 TGFBR3 CSPG4 CD44	1.18e-07	7	140	4	570
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	MYLK ISLR HMCN2 PTPRD PTPRS CNTN2 HSPG2 MXRA5 DSCAM	4.56e-06	161	140	9	593
GeneFamily	Immunoglobulin heavy locus at 14q32.33	IGHV3-30-5 IGHV3-38-3 IGHV3-49 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-9 IGHV3-30-3	1.05e-04	187	140	8	349
GeneFamily	Immunoglobulin like domain containing	FCRL2 OSCAR HMCN2 CNTN2 HSPG2 MXRA5 DSCAM FCRL4	1.31e-04	193	140	8	594
GeneFamily	Fibronectin type III domain containing	MYLK PTPRD PTPRH PTPRS CNTN2 DSCAM TNXB	2.50e-04	160	140	7	555
GeneFamily	Cadherin related	CDH23 FAT1 DCHS1	2.85e-04	17	140	3	24
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRD PTPRH PTPRS	5.46e-04	21	140	3	813
GeneFamily	Clustered protocadherins	PCDHGB2 PCDHB6 PCDHB3 PCDHAC2	1.53e-03	64	140	4	20
GeneFamily	Fibulins	HMCN2 FBLN7	1.62e-03	8	140	2	556
GeneFamily	Zinc fingers C2H2-type\|Sp transcription factors	SP3 SP4	2.07e-03	9	140	2	755
GeneFamily	Mannosyl-glycoprotein N-acetylglucosaminyltransferases	MGAT4B MGAT4A	2.07e-03	9	140	2	435
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ADNP2 ZHX1	5.85e-03	15	140	2	529
GeneFamily	Dyneins, axonemal	DNAH6 DNAH3	7.50e-03	17	140	2	536
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	TRERF1 EP400 ZSCAN20	8.03e-03	53	140	3	532
GeneFamily	X-linked mental retardation\|Angiotensin receptors	KDM5C BRWD3 HSD17B10	8.03e-03	53	140	3	103
GeneFamily	Sulfatases	GNS ARSG	8.40e-03	18	140	2	410
GeneFamily	CD molecules\|Killer cell immunoglobulin like receptors	KIR2DL5B KIR2DL5A	8.40e-03	18	140	2	620
Coexpression	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN	KDM5C INTS1 DAG1 ARHGEF17 GNS UBR2 CAD EP400 SYNM METTL13 LRP4 EP300	1.81e-06	276	203	12	M3063
Coexpression	GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN	IL10 ATG13 ALOX15B CAD PCDHB6 PMEL ITIH5 TGFBR3 CNNM1 GAA	3.26e-06	196	203	10	M5557
Coexpression	GSE6674_CPG_VS_PL2_3_STIM_BCELL_DN	TPR ARMCX4 BRAF AHR MRI1 NRF1 LATS1 SEC24C USPL1 GAA	3.90e-06	200	203	10	M6938
Coexpression	PEREZ_TP53_TARGETS	KLHL28 VPS13C EMILIN3 ALDH1L1 ADGRV1 ARHGEF17 BAP1 TECPR2 CAMTA1 CNTN2 NPNT MXRA5 SYNM DOCK8 RIPK4 FCHO2 ADAM12 TRIM3 ITIH5 DUOXA1 CSPG4 HPS6 SPRTN GAA	2.14e-05	1201	203	24	M4391
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SPAM1 VPS13C DGKB ADGRV1 OTOGL AGFG1 AHR SEMA6B HCN1 MUC19	1.65e-08	186	205	10	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	nucseq-Epithelial-Epithelial_Neuro-Secretory-PNEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DGKB ADARB2 CDK5R2 HCN1 PCDHB3 GRIA2 SEZ6L2 KLHDC8A RIMS2	1.04e-07	171	205	9	f4321133190a3df9d31f5d4021a464d3840145f1
ToppCell	nucseq-Epithelial-Epithelial_Neuro-Secretory-PNEC-PNEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DGKB ADARB2 CDK5R2 HCN1 PCDHB3 GRIA2 SEZ6L2 KLHDC8A RIMS2	1.04e-07	171	205	9	ed4fb6c84579d99df33de5f8f928c3cd2f3d3d72
ToppCell	nucseq-Epithelial-Epithelial_Neuro-Secretory\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DGKB ADARB2 CDK5R2 HCN1 PCDHB3 GRIA2 SEZ6L2 KLHDC8A RIMS2	1.10e-07	172	205	9	d0cdedd734406988a9a93d7300c7b1a8b4b45c38
ToppCell	PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	MYLK DGKB ARHGEF17 CPED1 PTPRD PTPRS NPNT HIF3A LRP4	2.67e-07	191	205	9	e7c605b56934d1383237c1f946dbccef25d91368
ToppCell	droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAT4A GBP1 FBP2 PTPRH DOCK8 APBB1 FCHO2 CD44	1.57e-06	175	205	8	f7cd2ef79d91d64976fcdb5f1e7343b24ba27456
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AVL9 PLXND1 DOCK6 HSPG2 ADNP2 FCHO2 TGFBR3 CSF1	2.37e-06	185	205	8	bdd2e6cb20294b39a9d856004bf57ba69cf877e2
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	ATP6V1B1 DACT2 ISLR FAT1 PTPRD NPNT HSPG2 ADAM12	2.68e-06	188	205	8	de6f4889e0c5f39fbbaefd85526f645c6afa09d5
ToppCell	3'-Adult-Distal_Rectal-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYLK DGKB ARHGEF17 CPED1 SYNM PERM1 ITIH5 CSPG4	2.78e-06	189	205	8	43e131458d8a4b120f7a5fb3d0c5650abded15f6
ToppCell	3'-Adult-Distal_Rectal-Mesenchymal-Pericytes\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYLK DGKB ARHGEF17 CPED1 SYNM PERM1 ITIH5 CSPG4	2.78e-06	189	205	8	d69b7a01dd4d6ad043bb6210e9ab34b49578389c
ToppCell	(1)_Osterolineage_cells-(10)_OLC-1\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	PLB1 ISLR FAT1 PTPRD PTPRS ADAM12 CSF1 LRP4	2.78e-06	189	205	8	46c5b975fb9d33017f2d9b7770d45a8bdf95baa2
ToppCell	3'-Adult-Distal_Rectal-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYLK DGKB ARHGEF17 CPED1 SYNM PERM1 ITIH5 CSPG4	2.78e-06	189	205	8	2b5f1b4f173a224342ea4f10b193ee33b7662699
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VPS13C ISLR CPED1 PTPRD FBLN7 ITIH5 TGFBR3 TNXB	3.13e-06	192	205	8	11088878043a6ff95ba1970361256a82e434b80a
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	KLHL28 AVL9 DAG1 ADGRV1 MGA GNS GNL3L LATS1	3.25e-06	193	205	8	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	nucseq-Mesenchymal-Myocytic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYLK ISLR ARHGEF17 ADARB2 FAT1 MXRA5 SYNM CSPG4	3.38e-06	194	205	8	2d66091097e106c7bee22e5281f50724700bdf8d
ToppCell	facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DACT2 ISLR FLNB ITIH5 TGFBR3 CSF1 DUOXA1 TNXB	3.64e-06	196	205	8	ed6047b48b6a96baa6a90c7af784e7c34b32824d
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ISLR PLXND1 SEMA6B HSPG2 TGFBR3 DCHS1 TNXB EPAS1	3.93e-06	198	205	8	259fbcc0f2ac281a3e4d693de45b986fe5e24841
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYLK DGKB CPED1 NELL2 NPNT SYNM GRIA2 HIF3A	3.93e-06	198	205	8	22e766df1276c5b14aa0d83f434f47140ebb98ea
ToppCell	ILEUM-non-inflamed-(8)_Fibroblast\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	MYLK ISLR TSC22D1 NPNT FLNB MXRA5 ITIH5 TNXB	4.07e-06	199	205	8	6a0df9a2f30480043f9c1d7fbdede17eb0910cac
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYLK ISLR ARHGEF17 CPED1 FAT1 SYNM PERM1 CSPG4	4.23e-06	200	205	8	c06426f877919bdd267ea2fd7e7973c6619832ae
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PLXND1 DOCK6 SEMA6B HSPG2 TGFBR3 DCHS1 TNXB EPAS1	4.23e-06	200	205	8	2e47888e041ec3d265425d1df97b6665c6da889c
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	DACT2 ARHGEF17 FAT1 NPNT MXRA5 ADAM12 CSF1 CSPG4	4.23e-06	200	205	8	ad3fb8ef0be45032369d1325024787fbe1dfb8d6
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PLXND1 DOCK6 SEMA6B HSPG2 TGFBR3 DCHS1 TNXB EPAS1	4.23e-06	200	205	8	50fa0f8a3e490d5941b34e66a10158eba6c909d4
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD8-Trm/em_CD8\|GI_small-bowel / Manually curated celltypes from each tissue	PDCD1 NELL2 SYNM PMEL ITIH5 TGFBR3 CD44	4.77e-06	144	205	7	a4bb274d553c29c8299354de757ecc5634008c68
ToppCell	wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	KLHL28 FBP2 ISLR PTPRD PCDHB6 ITIH5 DCHS1	1.21e-05	166	205	7	65dafed953b01a9830b54309af75c7a561e88336
ToppCell	lung-Ciliated_Epithelia\|lung / shred on tissue and cell subclass	CRNN DNAH6 CCDC40 DNAH3 CAPS ERICH5 CFAP69	1.26e-05	167	205	7	26cf1cfa58ee74794449a87eb19cd896e1ec8892
ToppCell	3'-Pediatric_IBD-SmallIntestine-Mesenchymal-stromal_related-FDC\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FBP2 SYNM PCDHB6 PCDHAC2 ADAM12 ITIH5 EPAS1	1.36e-05	169	205	7	49a54fb2ea9db5c45e107f304838c536908308bb
ToppCell	droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GBP1 FBP2 PTPRH DOCK8 APBB1 FCHO2 CD44	1.41e-05	170	205	7	a121e10099faaeb60251eec162f38caf7c4238c2
ToppCell	Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231\|Adult / Lineage, Cell type, age group and donor	DGKB ADARB2 HCN1 GRIA2 CASR HPS6 RIMS2	1.70e-05	175	205	7	8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18
ToppCell	Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Adult / Lineage, Cell type, age group and donor	DGKB ADARB2 HCN1 GRIA2 CASR HPS6 RIMS2	1.70e-05	175	205	7	4db1a3c284488b3f6de7568363f176d74e2a4587
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ATP6V1A ATP6V1B1 DGKB ADARB2 MVB12B KRT7 ITIH5	1.90e-05	178	205	7	51d2188406f04329311b2efd1108fc36617a860e
ToppCell	15-Distal-Epithelial-Neuroendocrine\|Distal / Age, Tissue, Lineage and Cell class	DGKB PTPRH CDK5R2 CNTN2 DCDC2 ERICH5 SEZ6L2	1.97e-05	179	205	7	bc04789f0fbd293fdcea66acba8cf227af251b7a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ATP6V1A DGKB ADARB2 MVB12B KRT7 DOCK8 ITIH5	2.04e-05	180	205	7	cfc8bfbfd3617aabbb49f9730c29b673ca157e74
ToppCell	Ciliated_cells-B-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	NELL2 ZSCAN1 CRNN DNAH6 CCDC40 CAPS CFAP69	2.04e-05	180	205	7	bdea5ec6b60fc8c7cce4d71db5da74ac8675e211
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PLB1 DAG1 CPED1 NPNT HSPG2 KRT7 TRIM3	2.19e-05	182	205	7	573771130247e869e4e58f22d4a1cb31989635cf
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PLB1 DAG1 CPED1 NPNT HSPG2 KRT7 TRIM3	2.19e-05	182	205	7	6cfaa2b3b3974c13b01c943f4adb70768dcc35e4
ToppCell	normal_Lung-Fibroblasts-Myofibroblasts\|normal_Lung / Location, Cell class and cell subclass	MYLK ISLR ZNF469 HMCN2 PTPRD MXRA5 ADAM12	2.35e-05	184	205	7	0b336489c10e8c3c957795dd845454f03404382b
ToppCell	Mesenchymal_cells-Osteo-CAR\|World / Lineage and Cell class	PLB1 ISLR FAT1 PTPRD TGFBR3 CSF1 LRP4	2.43e-05	185	205	7	16f1588893d09c864e0cb4f837a1b972a1a57baa
ToppCell	tumor_Lymph_Node_/_Brain-Fibroblasts-Undetermined\|Fibroblasts / Location, Cell class and cell subclass	GBP1 PTPRD PTPRS ARSG METTL13 CFAP69 DCXR	2.52e-05	186	205	7	403ac98f72a42721f84fbd7826f251a88ae534a2
ToppCell	Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DGKB PTPRH CDK5R2 HCN1 GRIA2 KLHDC8A RIMS2	2.52e-05	186	205	7	b45cce768e4bf91da194fd9660cab7520dfb15ac
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	TPR SP3 MYLK BRWD3 GNL3L SPRTN EP300	2.52e-05	186	205	7	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DGKB ARHGEF17 CPED1 DOCK8 ITIH5 DUOXA1 CSPG4	2.61e-05	187	205	7	ec4b694487cc446999c7b27b119950a4f252c4b3
ToppCell	droplet-Lung-LUNG-30m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK ARHGEF17 PTPRD NPNT TGFBR3 CSPG4 TNXB	2.61e-05	187	205	7	976b74d081b7fba8620768613cc26f9262cd7b16
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ARHGEF17 ADARB2 PTPRD OTOGL DOCK6 SYNM CSPG4	2.61e-05	187	205	7	86250acf088ec0c4800a0dfa031b0d4f7e52c342
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-25\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DACT2 ISLR ADGRV1 ITIH5 CSF1 DUOXA1 TNXB	2.61e-05	187	205	7	0d4b7da81036c2aa678654b9fe49c939d08fcd9b
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DGKB ARHGEF17 CPED1 DOCK8 ITIH5 DUOXA1 CSPG4	2.61e-05	187	205	7	530e4e6d91b5c0d9aa4543caa2b734a1674c5788
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	ISLR FAT1 DOCK6 NPNT MXRA5 GRIA2 SEZ6L2	2.70e-05	188	205	7	ed92cddf47defea2f904d36c7ae05ffa323349a9
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.4\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	OSCAR SIGLEC5 AGFG1 ITIH5 CSF1 CD44 GAA	2.79e-05	189	205	7	a59025e82fabd9d60e2438dee85b2644478cc7c8
ToppCell	droplet-Lung-immune-endo-depleted\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK ISLR PTPRD NPNT HSPG2 LRP4 TNXB	2.79e-05	189	205	7	c3fb363bb0156ffb3367c200f548faebda64ab4a
ToppCell	droplet-Lung-immune-endo-depleted-3m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK ISLR PTPRD NPNT HSPG2 LRP4 TNXB	2.79e-05	189	205	7	2a2953f6b1b7d070d739dcaf7285fce6e097d9e4
ToppCell	Macrophages-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	OSCAR DTX4 GNS DOCK8 ITIH5 CSPG4 GAA	2.79e-05	189	205	7	c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9
ToppCell	droplet-Lung-3m\|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYLK ISLR PTPRD NPNT HSPG2 LRP4 TNXB	2.79e-05	189	205	7	5a636e952da9b1fd26aa17f7b129054f2da322b5
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-oligodendrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 PTPRD TSC22D4 CNTN2 APBB1 SEZ6L2 LRP4	2.79e-05	189	205	7	bab0fe55643d3ee750355a32b1ff6634fa5cf88d
ToppCell	E18.5-samps-Mesenchymal\|E18.5-samps / Age Group, Lineage, Cell class and subclass	MYLK CPED1 TSC22D1 PTPRD PTPRS TGFBR3 LRP4	2.79e-05	189	205	7	0c18d3de4720759cf802eefb4d0ddde2a9246a1a
ToppCell	droplet-Lung-immune-endo-depleted-3m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK ISLR PTPRD NPNT HSPG2 LRP4 TNXB	2.89e-05	190	205	7	9cd147a174017ebda23cc47b6d4552d898acd092
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SPRY3 ATXN7L1 BRWD3 AGFG1 FCHO2 TEP1 ADAM12	2.89e-05	190	205	7	63018acb7ad80415e861643162abdc2e55968ee4
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-smooth_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK DGKB ARHGEF17 TSC22D1 SYNM CSPG4 EPAS1	2.99e-05	191	205	7	8e8beb8e8a3b33cac83d3f7ce915a71e3654fdab
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	MYLK CPED1 PTPRD PTPRS NPNT ADAM12 LRP4	2.99e-05	191	205	7	3379d145d34f89150f7b06d1340022cfc6b4a6ce
ToppCell	facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DACT2 ISLR FLNB ITIH5 CSF1 DUOXA1 TNXB	3.09e-05	192	205	7	30cefa0990ba1f379f350bfbf994a78db145075e
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYLK DGKB ARHGEF17 FAT1 HSPG2 HCN1 CSPG4	3.09e-05	192	205	7	2cc712186e37fb21a964c032765c36a8b4a852cf
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CDH23 ISLR PLXND1 HSPG2 TGFBR3 CSF1 TNXB	3.19e-05	193	205	7	daefbfd3a3dd1351fbe94b9abfd807db44d56c24
ToppCell	ILEUM-inflamed-(8)_Smooth_muscle_cells\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	MYLK ISLR CPED1 FAT1 NPNT MXRA5 LRP4	3.19e-05	193	205	7	084c88f08ce0ecd6c9f4334caed370eb2154f896
ToppCell	droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ISLR HSPG2 FBLN7 ITIH5 TGFBR3 TNXB GAA	3.19e-05	193	205	7	45b5cab4dfeb0ed3b13631db5963740a792b810f
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYLK CDH23 ALDH1L1 PTPRS HIF3A TGFBR3 TNXB	3.30e-05	194	205	7	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Mesenchymal\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	GBP1 ISLR MXRA5 ADAM12 ITIH5 TGFBR3 EPAS1	3.30e-05	194	205	7	4bafe26573cb2ff966f4a688c5769da598eea415
ToppCell	PND07-28-samps-Mesenchymal\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	MYLK ISLR CPED1 PTPRD PTPRS NPNT TGFBR3	3.30e-05	194	205	7	68bcc1fe8dc8d5f23a12154fc9b41362fdef0b1d
ToppCell	PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYLK ISLR ARHGEF17 CPED1 NPNT HSPG2 CSPG4	3.30e-05	194	205	7	aaecde88bd54134a938e76cdf059c1c2653e4e77
ToppCell	PND01-03-samps-Mesenchymal\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	MYLK DGKB CPED1 PTPRD PTPRS TGFBR3 LRP4	3.30e-05	194	205	7	4f9bd0ded0dde1df885850714f29e73e992539a5
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Mesenchymal-choroid_plexus/mesenchymal-like_cells\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	GBP1 ISLR MXRA5 ADAM12 ITIH5 TGFBR3 EPAS1	3.30e-05	194	205	7	8ac0b63c7a89e5ff78bbdd8dd1960aa2422a85f7
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PLXND1 HMCN2 SEMA6B HSPG2 HIF3A ITIH5 EPAS1	3.41e-05	195	205	7	6bdef651cf73d7381e5012d0eb3c809138fb6b92
ToppCell	facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ISLR CPED1 HSPG2 ITIH5 TGFBR3 TNXB GAA	3.41e-05	195	205	7	69a29d03e664b72f32d41876510c62345c3aed31
ToppCell	ASK440-Endothelial-Endothelium\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	MYLK HSPG2 MUC19 HIF3A TGFBR3 DCHS1 EPAS1	3.41e-05	195	205	7	304f0dc91bb57e98b0ca31d6bfb3ff9364e4da56
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-stromal_related\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MGAT4A PTPRD TSC22D4 SYNM PMEL ITIH5 CD44	3.41e-05	195	205	7	55b4030f078173b0136990fae87b6eaf44c58f33
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FAT1 AHR NPNT KRT7 MXRA5 CAPS PLEKHA2	3.41e-05	195	205	7	3d6d3de8ada6dce3dc789c15b50cc066e7100496
ToppCell	10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	EMILIN3 FAT1 NPNT MXRA5 ADAM12 ITIH5 LRP4	3.41e-05	195	205	7	ec12cfb2fce44cc2de4e198ef5af075e626f0329
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-stromal_related-ICC\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MGAT4A PTPRD TSC22D4 SYNM PMEL ITIH5 CD44	3.41e-05	195	205	7	19347b7e8d3ea67e0fddd948078abcab9d364a2d
ToppCell	11.5-Distal-Epithelial-Neuroendocrine\|Distal / Age, Tissue, Lineage and Cell class	DGKB CDK5R2 KRT7 DSCAM GRIA2 CNNM1 RIMS2	3.41e-05	195	205	7	eda6ebe52c48bd6a9044886e75f584f46c2556e7
ToppCell	facs-GAT-Fat-3m-Mesenchymal\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ISLR CPED1 HSPG2 ITIH5 TGFBR3 TNXB GAA	3.41e-05	195	205	7	1cffae2b08dbfa1c633ce24023e89b66d28b5431
ToppCell	facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ISLR CPED1 HSPG2 ITIH5 TGFBR3 TNXB GAA	3.41e-05	195	205	7	9cef6f18664518060af7c192310dddce6d70345a
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PLXND1 SEMA6B HSPG2 TGFBR3 DCHS1 TNXB EPAS1	3.52e-05	196	205	7	95c5b8fd4ebfae1f42de9b1475c1161d4a80e515
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MYLK ISLR ARHGEF17 MXRA5 ADAM12 ITIH5 EPAS1	3.52e-05	196	205	7	44e2df1b61e3819eae7e482bef0a733afe852d67
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MYLK ISLR ARHGEF17 MXRA5 ADAM12 ITIH5 EPAS1	3.52e-05	196	205	7	cb61757646653f89faba503cb5d99e5dd5197b4c
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ISLR ARHGEF17 MXRA5 ADAM12 ITIH5 CSPG4 EPAS1	3.52e-05	196	205	7	7acd782a587b7d331517f60daa8b5c2177bedfc7
ToppCell	PND01-03-samps-Mesenchymal-Matrix_fibroblast\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	MYLK DGKB CPED1 PTPRD PTPRS NPNT LRP4	3.52e-05	196	205	7	54f4cf778f95a9ff662e5c7520916a25e605bf95
ToppCell	PND28-Mesenchymal\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYLK ISLR CPED1 PTPRD NPNT HSPG2 CSPG4	3.52e-05	196	205	7	119265efd2219f328d8152dbee52af8327aec89c
ToppCell	metastatic_Lymph_Node-Fibroblasts\|metastatic_Lymph_Node / Location, Cell class and cell subclass	MYLK DACT2 FBP2 ISLR HSPG2 MXRA5 TNXB	3.52e-05	196	205	7	275e153347caf94edc0c50021bbab49c8696fecb
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK ARHGEF17 CPED1 TSC22D1 SYNM GRIA2 CSPG4	3.64e-05	197	205	7	02e70768a917c5f097bc653e9e965a1000289d2e
ToppCell	5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BTBD6 PLXND1 PTPRD HIF3A PRDM4 CSF1 GAA	3.64e-05	197	205	7	789c97ca9d1e28df3353140046047f11fbccc1d0
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PLXND1 GRPEL2 DOCK6 SEMA6B HSPG2 ITIH5 EPAS1	3.64e-05	197	205	7	a312d9cf4ced949307eb9620be4eed926300b892
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK ARHGEF17 CPED1 TSC22D1 SYNM GRIA2 CSPG4	3.64e-05	197	205	7	8b3bf5b45e49bf1c60e4d2703b470bb890385f67
ToppCell	Bronchial_Brush-Epithelial-Basal_1\|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	RNF168 DACT2 ISLR PTPRD KRT5 MXRA5 EPAS1	3.64e-05	197	205	7	f5d87824c0020c95d89e069fd9f70b49e5d5fcea
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYLK DGKB CDH23 CPED1 OTOGL SYNM HIF3A	3.64e-05	197	205	7	ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7
ToppCell	Transplant_Alveoli_and_parenchyma-Mesenchymal-Smooth_muscle\|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X	MYLK CPED1 TSC22D1 NPNT SYNM CSPG4 EPAS1	3.75e-05	198	205	7	89986c7756541df364df516329d10775ba0e78a4
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DGKB ADARB2 CDK5R2 HCN1 GRIA2 CASR RIMS2	3.75e-05	198	205	7	8f25e8dff42bad8e779ca618bdb1cb1610667962
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK ARHGEF17 CPED1 SYNM GRIA2 CSPG4 EPAS1	3.75e-05	198	205	7	77288df94286382170a266474ab85960519e8449
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK ARHGEF17 CPED1 SYNM GRIA2 CSPG4 EPAS1	3.75e-05	198	205	7	2ee195f20a4f91fa1dcad9eaf96d6086e3b0fb4a
ToppCell	Bronchial_Brush-Epithelial-Basal_1\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	RNF168 DACT2 ISLR PTPRD KRT5 MXRA5 EPAS1	3.75e-05	198	205	7	10a17d7c116dcd6cf847fe6f5d7196d887cad1f9
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DGKB ADARB2 CDK5R2 HCN1 GRIA2 CASR RIMS2	3.75e-05	198	205	7	e3e0aa3ef20b2370f5b133048510677aaa562dfa
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK ISLR ARHGEF17 CPED1 SYNM CSPG4 EPAS1	3.75e-05	198	205	7	daf367b699726286f0f0f7b4f3a6cf70c462fbeb
ToppCell	Parenchyma_COVID-19-Endothelial-TX-Lymphatic\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	GRPEL2 DOCK6 HSPG2 SYNM HIF3A TGFBR3 TNXB	3.88e-05	199	205	7	88f33b8dcd837abfa1d12c28719e073a7da6e979
Disease	obsolete_red blood cell distribution width	SPRY3 SP3 AVL9 RC3H1 CDH23 ARFIP1 PTPRH TSC22D4 COG5 DOCK6 SEC23B CD300LF EP400 NRF1 DOCK8 NICN1 FCHO2 ARSG RNF123 NUTM2F ATP2B3 EP300	8.30e-05	1347	194	22	EFO_0005192
Disease	autosomal recessive limb-girdle muscular dystrophy type 2H (implicated_via_orthology)	TRIM3 TRIM32	1.28e-04	3	194	2	DOID:0110282 (implicated_via_orthology)
Disease	Acute Erythroblastic Leukemia	DHODH CAD	2.56e-04	4	194	2	C0023440
Disease	Adenoid Cystic Carcinoma	FAT1 DTX4 MGA KRT5 EP300	5.30e-04	100	194	5	C0010606
Disease	Pigmented Basal Cell Carcinoma	BAP1 KRT5 LATS1	8.12e-04	28	194	3	C1368275
Disease	Carcinoma, Basal Cell	BAP1 KRT5 LATS1	9.01e-04	29	194	3	C4721806
Disease	creatinine measurement	ATP6V1B1 PSMD1 ALDH1L1 ADGRV1 ADARB2 BRWD3 AHR OPLAH DCDC2 DSCAM NRF1 RNF123 DUOXA1 CSPG4 DOCK7 EPAS1	9.41e-04	995	194	16	EFO_0004518
Disease	Hereditary spherocytosis	DHODH CAD	1.17e-03	8	194	2	C0037889
Disease	PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME	KDM5C BRWD3	1.17e-03	8	194	2	C0796250
Disease	monocyte count	FCRL2 MGAT4B KLHDC7B CDH23 SIGLEC5 ADGRV1 ONECUT1 ZNF276 PTPRH PKD1 AHR VWA2 FLNB CD300LF DOCK8 TGFBR3 CSF1 PLEKHA2 FCRL4	1.18e-03	1320	194	19	EFO_0005091
Disease	Generalized Epilepsy with Febrile Seizures Plus	ADGRV1 HCN1	1.50e-03	9	194	2	C3502809
Disease	feeling "fed-up" measurement	DAG1 HCN1 RNF123 LRP4	1.61e-03	76	194	4	EFO_0009588
Disease	hepatitis B (is_implicated_in)	IL10 PDCD1 DOCK8	1.84e-03	37	194	3	DOID:2043 (is_implicated_in)
Disease	Anemia, Sickle Cell	DHODH CAD	1.87e-03	10	194	2	C0002895
Disease	Nonsyndromic Deafness	CDH23 ADGRV1 OTOGL DCDC2	2.03e-03	81	194	4	C3711374
Disease	thioredoxin domain-containing protein 12 measurement	SPAM1 NICN1 RNF123	2.15e-03	39	194	3	EFO_0008298
Disease	Neuroendocrine Tumors	BAP1 BRAF	2.27e-03	11	194	2	C0206754
Disease	Colorectal Carcinoma	ISLR ALDH1L1 ADARB2 FAT1 PTPRD BRAF PTPRS VWA2 DNAH3 CAD DCHS1 EP300	2.48e-03	702	194	12	C0009402
Disease	Neoplasm of uncertain or unknown behavior of breast	BAP1 BRAF EP300	2.48e-03	41	194	3	C0496956
Disease	Breast adenocarcinoma	BAP1 BRAF EP300	2.48e-03	41	194	3	C0858252
Disease	Adenocarcinoma of lung (disorder)	BAP1 BRAF AHR LATS1 HSD17B10 EP300	2.49e-03	206	194	6	C0152013
Disease	C-reactive protein measurement	TRERF1 SP3 VPS13C ONECUT1 ZNF469 ZNF276 NR1I2 PKD1 CAMTA1 UBR2 FBLN7 CAD CD300LF HIF3A YEATS2 LATS1 DOCK7	2.66e-03	1206	194	17	EFO_0004458
Disease	Cooley's anemia	DHODH CAD	2.72e-03	12	194	2	C0002875
Disease	Thalassemia Intermedia	DHODH CAD	2.72e-03	12	194	2	C0271979
Disease	Thalassemia Minor	DHODH CAD	2.72e-03	12	194	2	C0085578
Disease	beta Thalassemia	DHODH CAD	2.72e-03	12	194	2	C0005283
Disease	systemic lupus erythematosus (implicated_via_orthology)	PDCD1 RC3H1 EP300	2.85e-03	43	194	3	DOID:9074 (implicated_via_orthology)
Disease	Paraganglioma	BAP1 EPAS1	3.20e-03	13	194	2	C0030421
Disease	level of Phosphatidylinositol (18:1_18:1) in blood serum	DOCK6 DOCK7	3.20e-03	13	194	2	OBA_2045159
Disease	Connective Tissue Diseases	ZNF469 PKD1	3.20e-03	13	194	2	C0009782
Disease	response to hydrochlorothiazide, fasting blood glucose measurement	ADARB2 OTOGL ADAM12	3.45e-03	46	194	3	EFO_0004465, EFO_0005202
Disease	anti-basement membrane glomerulonephritis (implicated_via_orthology)	IL10 CSF1	3.72e-03	14	194	2	DOID:4780 (implicated_via_orthology)
Disease	autosomal dominant polycystic kidney disease (implicated_via_orthology)	PKD1 LATS1	3.72e-03	14	194	2	DOID:898 (implicated_via_orthology)
Disease	unipolar depression, mood disorder, response to antidepressant	PTPRD NRF1	3.72e-03	14	194	2	EFO_0003761, EFO_0004247, GO_0036276
Disease	cerebellum cortex volume change measurement	PTPRD EPAS1	3.72e-03	14	194	2	EFO_0021497
Disease	Autosomal recessive limb-girdle muscular dystrophy	DAG1 TRIM32	3.72e-03	14	194	2	cv:C2931907
Disease	renal cell carcinoma (biomarker_via_orthology)	CAD EPAS1	3.72e-03	14	194	2	DOID:4450 (biomarker_via_orthology)
Disease	cholestasis (biomarker_via_orthology)	ALDH1L1 NR1I2 CD44	4.13e-03	49	194	3	DOID:13580 (biomarker_via_orthology)
Disease	Opioid use measurement	PTPRD MVB12B	4.27e-03	15	194	2	EFO_0009937
Disease	P wave duration	HCN1 EPAS1	4.27e-03	15	194	2	EFO_0005094
Disease	third ventricle volume measurement	PTPRD HPS6	4.27e-03	15	194	2	EFO_0010335
Disease	Hemoglobin F Disease	DHODH CAD	4.27e-03	15	194	2	C0019025
Disease	Pancreatic Neoplasm	BAP1 AHR CD44 EP300	4.35e-03	100	194	4	C0030297
Disease	platelet component distribution width	SIGLEC5 PTPRH TSC22D4 CAMTA1 CCDC40 NRF1 DOCK8 METTL13 DOCK7 TNXB EPAS1 GAA	4.43e-03	755	194	12	EFO_0007984
Disease	Malignant neoplasm of pancreas	BAP1 AHR CD44 EP300	4.66e-03	102	194	4	C0346647
Disease	T-Cell Lymphoma	MGA EP300	4.86e-03	16	194	2	C0079772
Disease	Malignant neoplasm of breast	TRERF1 IL10 BAP1 PTPRD BRAF OTOGL SURF1 AHR TSC22D4 KRT5 FLNB ADAM12 CSF1 ZFP64 EP300	5.09e-03	1074	194	15	C0006142
Disease	Hepatomegaly	NR1I2 AHR DSCAM	5.43e-03	54	194	3	C0019209
Disease	response to radiation, Urinary retention	PTPRS CAMTA1	5.48e-03	17	194	2	GO_0009314, HP_0000016
Disease	Vascular Diseases	MYLK AHR	5.48e-03	17	194	2	C0042373
Disease	PR interval	DAG1 DGKB ALDH1L1 ZNF469 FAT1 CAMTA1 HSPG2 HCN1 EPAS1	5.70e-03	495	194	9	EFO_0004462
Disease	Ciliopathies	CDH23 ADGRV1 CCDC40 TRIM32	6.08e-03	110	194	4	C4277690
Disease	melanoma	PDCD1 BAP1 BRAF PMEL CNNM1 EP300	6.13e-03	248	194	6	C0025202
Disease	Adrenocortical carcinoma	BAP1 BRAF	6.14e-03	18	194	2	C0206686
Disease	level of Phosphatidylinositol (18:0_18:1) in blood serum	DOCK6 DOCK7	6.14e-03	18	194	2	OBA_2045155
Disease	respiratory syncytial virus infectious disease (is_marker_for)	IL10 PDCD1	6.14e-03	18	194	2	DOID:1273 (is_marker_for)

Protein segments in the cluster

Peptide	Gene	Start	Entry
SGQGIEEATGLPQTV	AHR	186	P35869
VNGGVGVQTPSLLSD	EP300	516	Q09472
NVNITLQSVGPVVGG	EP400	71	Q96L91
VNVPVLGSSTLLQGG	EPAS1	846	Q99814
EIPDGQITVGQRIGS	BRAF	451	P15056
EGFQTVRVGTVGTPV	ATG13	166	O75143
PETNGVIRSAGGVPI	CAMTA1	721	Q9Y6Y1
TVVGQGQLTEEPGSA	C16orf86	16	Q6ZW13
TTQLTQGPAGRTLGQ	CAPS	61	Q13938
VVPQGGQGTIDTAVL	CSPG4	1136	Q6UVK1
RPLENTGQTVLVVGG	CPED1	846	A4D0V7
TNGTGVQGGQIPELI	BTBD6	521	Q96KE9
TVQETGLQGPVGGDQ	CASR	1026	P41180
VGVSRGPSPVSLGNQ	FCHO2	526	Q0JRZ9
VSGVLLETQPSGGQA	FCRL4	286	Q96PJ5
GPGGQLAETNLQVTV	ADGRV1	1216	Q8WXG9
QGSDLIVPAGGQRTQ	ARFIP1	91	P53367
IRPIQGSQGSSSPVE	BAP1	586	Q92560
VPGVQTLLGVGRQSL	BRWD3	91	Q6RI45
QGGASRPVIGTNAVS	ADAM12	586	O43184
GVTRNFAVTSVGGLP	ARSG	101	Q96EG1
GLRGPGLIISTQEQG	APBB1	131	O00213
GGSVVLGQVDSRLAP	DTX4	41	Q9Y2E6
SPRGTLVGNVTGAVD	CDH23	2741	Q9H251
GGSPRRVIVQASTGE	CDK5R2	171	Q13319
QIVAGSQGETLPGAR	ARMCX4	1031	Q5H9R4
RQVVAVTGDGTNDGP	ATP2B3	786	Q16720
PADIVRQVGAVGGSS	ATXN7L1	726	Q9ULK2
GQTAPLRVISAGQVV	ADNP2	501	Q6IQ32
GNTVTQLIPRGTDPS	RC3H1	501	Q5TC82
GGELRFTVTQRSQPG	HSPG2	1006	P98160
QRVTVSSLPGFQPVG	PCP2	81	Q8IVA1
LTQPRGTENREVGIG	RFX5	406	P48382
GEGTVPVRGPSAVQT	ADARB2	526	Q9NS39
PGTQTVTLGGIFQLG	DAO	231	P14920
LSAQPGPTVRTGENV	KIR2DL5A	126	Q8N109
NVSGETVSVTPVPGQ	RBL2	711	Q08999
VGGQAQAVTGSIQPL	RBL2	766	Q08999
QSIVQGPGTLGRVVD	ARHGEF17	801	Q96PE2
QNSVGRVGPDALPVS	FBLN7	66	Q53RD9
GTIPRDLGVGEQITT	FAT1	576	Q14517
SLQPAVQIGNGRTGV	MGAT4A	121	Q9UM21
VQVQDGGSPPRSTTG	DCHS1	1181	Q96JQ0
PARSATGVIIVGLQG	DCHS1	2046	Q96JQ0
GGAGETTGQQRPLQV	MIR1915HG	41	Q5T4H9
TFPTRQPGLGSQDVV	MYLK	381	Q15746
VQLVESGGGVVQPGR	IGHV3-30-5	21	P0DP03
TGGGAEVSPQTQQER	MAP10	201	Q9P2G4
GRANGEVLPTPGQET	LYSMD1	131	Q96S90
ASGGVQNSGIVREAP	NEDD1	331	Q8NHV4
ARVLPGQAVTGVRGS	NEIL3	16	Q8TAT5
LELGESTTGVRQVPG	NELL2	36	Q99435
VLLTGVRASPGQGTQ	IL10	11	P22301
EPVVQSVRGAGTQPG	ITIH5	646	Q86UX2
RVRLTEGQGSEIQPG	MGA	291	Q8IWI9
SSPEQPIGQGRIRVG	INTS1	1326	Q8N201
PAVRVGQGRTGVSVV	MGAT4B	131	Q9UQ53
ASTPPGGITVDNRVQ	NPNT	361	Q6UXI9
GGPVGAGIREVTINQ	KRT7	56	P08729
GQRGISSVPVGRQPI	LATS1	316	O95835
VQLVESGGGVVQPGR	IGHV3-30-3	21	P0DP02
VAEGLGQVTTIVGQP	HMCN2	1721	Q8NDA2
VQLVESGGGLVQPRG	IGHV3-38	21	A0A0C4DH36
VQLVESGGGLVQPGR	IGHV3-9	21	P01782
VQLVESRGVLVQPGG	IGHV3-38-3	21	P0DTE1
LSGEGVGPVNISVVT	KRT5	481	P13647
QPTRVSEAGTTVPGQ	DAG1	386	Q14118
QAGGLATTGTQPVLD	FBP2	291	O00757
GIVEITSPNVGTDGR	ISLR	276	O14498
LSAQPGPTVRTGENV	KIR2DL5B	126	Q8NHK3
GVSSNSIQIGGLFPR	GRIA2	21	P42262
PNVFTVVTRGAGIGG	FLNB	1346	O75369
RPAGQFQTLVVGVVG	PDCD1	161	Q15116
GAAVGQLPITIQVGN	PLXND1	1241	Q9Y4D7
QAERPGGTTVVSPGA	MUC19	6816	Q7Z5P9
DGGDPPQSGTTQIRI	PCDHGB2	216	Q9Y5G2
GLIARGVPGAIVNVS	DCXR	121	Q7Z4W1
EDVNTLQGGGQPVVT	FKBP15	391	Q5T1M5
GTAREPNPSVTGAQV	ONECUT1	266	Q9UBC0
SNPDGTVSLIQVGTG	NRF1	311	Q16656
TLSGGIQVNGPRLES	GBP1	281	P32455
TTELVVLQGRVGPAG	GNL1	536	P36915
GPEVTVTRAGLPGAQ	AMH	171	P03971
ITRGQIVGTPGSSGE	MCM10	226	Q7L590
ERTGTQPLGVQGLTE	NR1I2	131	O75469
VQLVESGGGLVQPGR	IGHV3-49	21	A0A0A0MS15
AGVGVQPGTVALVRQ	GRPEL2	186	Q8TAA5
VTEGQGDRQPTVVGE	CRNN	426	Q9UBG3
PDQGGQRGVIINTAS	HSD17B10	141	Q99714
TGVGVVASRNRAPTG	MVB12B	51	Q9H7P6
NSIGQGPPSESVVTR	PTPRS	406	Q13332
GAQPATVVTPGVNVT	OSCAR	36	Q8IYS5
DGGIPARSGTAQISV	PCDHAC2	231	Q9Y5I4
GLGPAQLVGRQTLAT	RIMS2	1241	Q9UQ26
GDASQVIGPLTEGQR	COG5	561	Q9UP83
AGGAVIPTGTPERAQ	FAM157B	231	P0CG42
SERVQSISLGQGQGP	DNAH6	3566	Q9C0G6
GLQAGGRSTVPQRVT	HCN1	826	O60741
IITTVGPELQGNGAT	HEATR5B	1006	Q9P2D3
IGGIATNVRPGVTIR	KLHL28	336	Q9NXS3
ESPRGPAGLNTIQTG	DACT2	306	Q5SW24
GSVGPTVNQGPLEVA	DOCK6	1936	Q96HP0
QGSVGTTVNQGPLEV	DOCK7	2026	Q96N67
VLQGSVGATVNQGPL	DOCK8	1976	Q8NF50
GQQPADVTGTALPRV	CSF1	356	P09603
QEGGANTTSGPIRTP	CD44	631	P16070
QPATISVPRDRTGQG	DNAH3	131	Q8TD57
ANTGQVVLIPGLISG	AVL9	376	Q8NBF6
QITGPTTVNGLERGS	CD300LF	21	Q8TDQ1
VGRLTGSTEEPQGQV	CCDC40	181	Q4G0X9
ESTGVQNLLSGRVPG	GPAT2	116	Q6NUI2
VTVDGQGLQVTPVPG	DGKB	421	Q9Y6T7
VQIPGRVFLVTGGNS	DHRS12	36	A0PJE2
PGGVVVRDIGDTTIQ	CNTN2	611	Q02246
VQLVESGGGVVQPGR	IGHV3-30	21	P01768
GLRRGVFITNETGQP	GAA	461	P10253
GVFGVAAGTRRPNVV	GNS	36	P15586
LVEAGGQPQPRSSET	KLHDC7B	56	Q96G42
IVAGGLGNQPTVLET	KLHDC8A	281	Q8IYD2
IGSPRINATGQGVTI	SPAM1	76	P38567
ALQAVTETQRGPGAP	EMILIN3	401	Q9NT22
TQARQGDPSTGPIIE	HSPA6	626	P17066
SLEIRAPGGQVTEGQ	FCRL2	206	Q96LA5
QVPFLSVGGDIGVRT	METTL13	371	Q8N6R0
TLQIAGELQPQGTVG	ERICH5	196	Q6P6B1
GGTRAVGTLQEAPVG	HPS6	296	Q86YV9
GLNTTVPSGGVVTVE	CFAP69	881	A5D8W1
GGVNITLTGTPVQQL	DUOXA1	106	Q1HG43
VTGVRGQVPPLVTTN	SEC24C	346	P53992
SRSQGEPVLALGTGQ	PERM1	86	Q5SV97
VTGGVQAPFGAVRNI	DCDC2	51	Q9UHG0
QSNGNVGLEPGIVSI	PRDM4	151	Q9UKN5
VTLGRGGQILTSPNQ	OTOGL	551	Q3ZCN5
STVQGVEVGPAPQGE	PKD1	471	P98161
DGGSPPRSGTAQINI	PCDHB3	216	Q9Y5E6
FTRTPVDQTGVSGGV	PTPRD	26	P23468
VQLVESGGGVVQPGR	IGHV3-33	21	P01772
GQGTVTVTLPVAGNV	NFYA	216	P23511
TVTLPVAGNVVNSGG	NFYA	221	P23511
GGSPPRSGTSEIQIQ	PCDHB6	216	Q9Y5E3
TNVGSDLVVGGVLPN	MOXD2P	76	A6NHM9
IVPGQVVDRSTGIGI	ALOX15B	421	O15296
PGVPVTSAQVVGGTQ	NUTM2F	131	A1L443
PGVPVTSAQVVGGTQ	NUTM2G	131	Q5VZR2
LTAQNGVGPGRISEI	DSCAM	1451	O60469
IGGVVVHTPISQNGG	PLEKHA2	151	Q9HB19
PDGTQRSGQVLEVAG	ATP6V1B1	71	P15313
LGAAGVQVQGVPVTI	SP4	541	Q02446
SIGSVGPDGQLGRQI	TRIM32	551	Q13049
GQRTPQGPVSATVEV	SYNM	1091	O15061
PQARSFTGGLGQLVV	TSC22D4	161	Q9Y3Q8
VNGGTTQGPRVPIIL	RHOT2	101	Q8IXI1
GGPVTVTDANLVLGR	OPLAH	386	O14841
AGGITQQIGATNVPL	EIF5B	661	O60841
GIVPGPNSEVGTILR	GNL3L	306	Q9NVN8
TQTQATVVSGGRGPQ	HIF3A	316	Q9Y2N7
TVVSGGRGPQSESIV	HIF3A	321	Q9Y2N7
LQVGDVRTSQGRPGV	NICN1	16	Q9BSH3
RVPIIGVGGVSSGQD	DHODH	326	Q02127
QNLRTVGTPIASVPG	PSMD1	266	Q99460
GGTLVLVSQDGIQRP	SGSM2	336	O43147
EAGPGTPGTAVVEQQ	SGSM2	681	O43147
LQGRSNLGTGVVPAA	SIGLEC5	426	O15389
GGLQVVINGLNSTEP	SIL1	226	Q9H173
GTPGATVTVTLRQGQ	SIAE	51	Q9HAT2
TDVNGVRIAAPGIGV	MRI1	306	Q9BV20
QSTVPGGPIGGQTRV	SURF1	251	Q15526
GGPIGGQTRVTLRNE	SURF1	256	Q15526
VGPGVTSGVNVNILS	TSC22D1	351	Q15714
GIQPSPVNVVGVTSA	TSC22D1	576	Q15714
GVGAGTTVIPVAQPQ	TSC22D1	676	Q15714
GPLTTAVTPNGVRGA	SEZ6L2	101	Q6UXD5
GAGSTPGNVLDVLTQ	PLB1	406	Q6P1J6
QVPTTEVVGTTPGQA	PMEL	326	P40967
PGVSVNAQTLDGRTP	RIPK4	641	P57078
SPSGQSIIRTQPGAG	SPRY3	106	O43610
TPIPQGGRGAIQFVT	SEC23B	471	Q15437
RPLPSTANVVVIGGG	SARDH	61	Q9UL12
GVVNVLPGSGSLVGQ	ALDH1L1	621	O75891
GTPSQSPVVGRSQGQ	AGFG1	176	P52594
PGGVAGSALVQVRVR	CNNM1	151	Q9NRU3
AGRTQIAPGSQTVLG	PTRH2	146	Q9Y3E5
NGGILTVSIDNPGAV	FYTTD1	226	Q96QD9
QAVTGVVSLGGRPVV	SEMA6B	306	Q9H3T3
VDVSGTGRPSPQNEG	USPL1	191	Q5W0Q7
TRVPQDVTQGPGATG	ZNF444	111	Q8N0Y2
GAGLVNVESTQGPRI	ZSCAN20	456	P17040
RTLAFNVPGGVVAVG	TEP1	1846	Q99973
RQSVGRGLQLTPGIG	TPR	2106	P12270
SQGQVEGRLGPSTVV	RNF123	81	Q5XPI4
PVQTLTLGQVAAGGA	SP3	491	Q02447
GTQEAVAGISVVPRG	ZSCAN1	271	Q8NBB4
GQRVGPVSAVGVTAP	TNXB	1446	P22105
GGQRVGPVSAIGVTA	TNXB	2376	P22105
GGQRVGPISVIGVTA	TNXB	2701	P22105
HGGQRVGPISVIGVT	TNXB	2916	P22105
GQRVGPVSAVGVTAP	TNXB	3026	P22105
RNNGISVLVVGVGPV	VWA2	656	Q5GFL6
DAPQTSQGRGTGTPV	ZNF276	281	Q8N554
VGQPGLVLTQVAGTN	ZHX1	391	Q9UKY1
GNPEREGSVSIVGAV	ATP6V1A	396	P38606
QIIGLGTQVSQRPGA	VPS13C	556	Q709C8
NVLAGQLRGVPVAGT	NAPRT	196	Q6XQN6
RVLGSVGGQLTPVSA	TECPR2	716	O15040
IDVSNPQTVGVGRGR	SNX3	31	O60493
LGQVLGTPSVAGSEN	RALGAPB	41	Q86X10
TLSPQISLGVGEQGA	RNF168	276	Q8IYW5
TAGNPGGQTVRERLT	CAD	361	P27708
VNGSPRISVTVGNIP	SPRTN	346	Q9H040
VGRVELGTGTEPPSQ	ZNF469	1566	Q96JG9
PVGTNGGVTVVGLVS	TMEM19	211	Q96HH6
LVQVQGVTAPVGSSG	ZNF524	66	Q96C55
VGERFSPGVGQVNAT	UBR2	761	Q8IWV8
NTTDTRVTVDGLGPG	PTPRH	256	Q9HD43
AGSVQIPGGTTVLVE	ZFP64	11	Q9NTW7
TAGQGPGQLQREVTL	TGFBR3	71	Q03167
IVSGGGGTIVAQPVQ	YEATS2	701	Q9ULM3
GQLQRPTGVAVDTNG	TRIM3	531	O75382
GSNVTVTPGPGEQTV	TRERF1	761	Q96PN7
VSRALGLVSGQEAGP	KDM5C	826	P41229
GTGSNVILVRSNLPG	LRP4	1281	O75096
PSGAVQRDQTVLEGG	MXRA5	481	Q9NR99